Publication:
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.

No Thumbnail Available
Date
2024-02-03
Authors
Wainberg Z. A.
Kang Y.
Lee K.
Qin S.
Yamaguchi K.
Kim I.
Saeed A.
Oh S. C.
Li J.
Turk H. M.
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Description
Keywords
Citation
Wainberg Z. A., Kang Y., Lee K., Qin S., Yamaguchi K., Kim I., Saeed A., Oh S. C., Li J., Turk H. M., et al., "Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.", Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2024
Page Views

1

File Downloads

0

Sustainable Development Goals